Global Osteoarthritis Pain Epidemiology and Patient Flow Analysis - 2017

Global Osteoarthritis Pain Epidemiology and Patient Flow Analysis - 2017

  • January 2017 •
  • Report ID: 4835061 •
  • Format: PDF
Fore Pharma announced the results of its Osteoarthritis Pain patients study in a new report ‘Global Osteoarthritis Pain Epidemiology and Patient Flow Analysis - 2017’.

The report provides insights into Osteoarthritis Pain epidemiology, Osteoarthritis Pain diagnosed patients, and Osteoarthritis Pain treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Osteoarthritis Pain derived from epidemiological analysis, percentage of patients diagnosed with Osteoarthritis Pain, and percentage of patients treated with a therapy.

The study helps executives estimate Osteoarthritis Pain market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Osteoarthritis Pain prevalence, Osteoarthritis Pain diagnosis rate, and Osteoarthritis Pain treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:
- Osteoarthritis Pain Patient Flow
- Osteoarthritis Pain Prevalence
- Osteoarthritis Pain Diagnosed Patients
- Osteoarthritis Pain Treated Patients